| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $84.7M | +84.6% |
| Cost of Revenue | $43.3M | +283.0% |
| R&D Expense | $70.6M | +37.2% |
| SG&A Expense | $53.3M | +88.3% |
| Operating Income | -$341.4M | -397.5% |
| Pre-tax Income | -$359.9M | -323.3% |
| Income Tax | -$9.2M | -336.3% |
| Net Income | -$350.7M | -294.3% |
| EPS (Basic) | -$1.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $198.2M | +108.1% |
| Current Assets | $255.5M | +125.0% |
| Total Assets | $554.0M | +266.6% |
| Current Liabilities | $67.7M | +179.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $371.3M | +202.0% |
| Stockholders' Equity | $182.7M | +548.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.9M | -59.5% |
| Capital Expenditures | $640K | +63.3% |
| Investing Cash Flow | -$12.4M | -3056.1% |
| Financing Cash Flow | $210.9M | +25.4% |
| Free Cash Flow | -$109.5M | -59.5% |
| -160.0% |
| EPS (Diluted) | -$1.04 | -160.0% |